Publications found:
58,333
Sort by:
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...
August 2018
90 pages
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...
August 2018
90 pages
Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...
August 2018
30 pages
Rabies Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...
August 2018
60 pages
Rotavirus Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...
August 2018
45 pages
Rubella (German measles) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...
August 2018
30 pages
Tetanus Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...
August 2018
65 pages
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...
August 2018
35 pages
Yellow Fever Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...
August 2018
40 pages